Medco's New Idea: PGx Program for Generics to Dispense 'Smarter' Treatments and Increase Savings

Under the Genetics for Generics program, Medco will aim to make "generic drugs work better with genetics" and "help the system afford innovative products that address true unmet need," according to Chief Medical Officer Robert Epstein.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.